Lifespan Cancer Institute among 6 groups studying digital symptom reporting benefit

PROVIDENCE – The Lifespan Cancer Institute is among six cancer programs nationally participating in the $9 million SIMPRO study investigating whether electronic reporting of symptoms decreases hospitalizations after surgery or chemotherapy. The SIMPRO, or Symptom Management Implementation of Patient Reported Outcomes in Oncology study, is funded by the National Cancer Institute in association with the…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -